DEGS1-mTORC1-driven lipid metabolic reprogramming fuels rhabdomyosarcoma progression and unveils a…

KRAS-driven metabolic reprogramming of enhanced MFSD2A-mediated lysophosphatidylcholine scavenging promotes survival and progression of pancreatic ductal adenocarcinoma
y. chen, C. Haffner, B. Chellakkan Selvanesan +24
bioRxiv5 Oct 2026PreprintAll rights reservedFull textOncologybioRxiv
MCT4-Associated Lactate Export Defines Myeloid Metabolic Reprogramming during Head and Neck Cancer Progression
T. Tilton, Y. M. Park, H. Zhu +2
bioRxiv13 Oct 2026PreprintCC BYFull textOncologybioRxiv
Hypoxia-inducible factor-1α–mediated metabolic reprogramming in sepsis-associated organ dysfunction: organ-specific metabolic mismatch and therapeutic perspectives
Yuge Wu, Jiantao Lu, Yue Mo +4
Frontiers in Immunology12 Oct 2026Peer-reviewedCC BY 4.0Full textOncologyPMCCrossrefEurope PMC
CD36-Mediated Lipid Metabolic Reprogramming in Hepatocellular Carcinoma: Crosstalk With Immunity, Ferroptosis, and Therapeutic Resistance.
Ankit Kumar Bijaraniya, Tao Lide
Cureus25 Sep 2026Peer-reviewedCC BYFull textOncologyEurope PMC
SLC25A39 potentiates the RXFP1/cAMP/PKA/CREB axis to drive metabolic reprogramming and tumor progression in ovarian cancer.
Tian Tian, Jiming Bai, Qian Li +5
Cell biology and toxicology3 Aug 2026Peer-reviewedCC BY-NC-NDFull text1 citedOncologyEurope PMCPMC

Cite

BibTeX

@article{krishnan2026degs1mtorc1driven,
  title = {{DEGS1-mTORC1-driven lipid metabolic reprogramming fuels rhabdomyosarcoma progression and unveils a therapeutic vulnerability}},
  author = {Priya D Gopal Krishnan and Kah Yong Goh and Kai Hung Chen and Chi Peng and Wen Xing Lee and Elizabeth A. Mendes and Shi Chee Ong and Sze Mun Choy and Qian Gou and Kanya Moolsuwan Ng and Kenon Chua and Shu-Yi Huang and Reshma Taneja and Corinne M. Linardic and Chih-Chiang Chan and Hong-Wen Tang},
  journal = {Nature Communications},
  year = {2026},
  month = oct,
  doi = {10.1038/s41467-026-79206-0},
  url = {https://www.nature.com/articles/s41467-026-79206-0},
  note = {CC BY-NC-ND 4.0},
}

RIS

TY  - JOUR
TI  - DEGS1-mTORC1-driven lipid metabolic reprogramming fuels rhabdomyosarcoma progression and unveils a therapeutic vulnerability
AU  - Priya D Gopal Krishnan
AU  - Kah Yong Goh
AU  - Kai Hung Chen
AU  - Chi Peng
AU  - Wen Xing Lee
AU  - Elizabeth A. Mendes
AU  - Shi Chee Ong
AU  - Sze Mun Choy
AU  - Qian Gou
AU  - Kanya Moolsuwan Ng
AU  - Kenon Chua
AU  - Shu-Yi Huang
AU  - Reshma Taneja
AU  - Corinne M. Linardic
AU  - Chih-Chiang Chan
AU  - Hong-Wen Tang
PY  - 2026
DA  - 2026/10/27
JO  - Nature Communications
DO  - 10.1038/s41467-026-79206-0
UR  - https://www.nature.com/articles/s41467-026-79206-0
SN  - 2041-1723
ER  -

Related

Cite